Intuitive Surgical Inc logo
ISRG

Intuitive Surgical Inc

MaveScore 46 Low model confidence
Last Price US$407.35 As of Jul 10, 2026
DCF Fair Price US$119.55 Research estimate · Jul 10, 2026 -71.0% vs price
Market Cap US$144.4b Company size context
7D Performance -4.64% Past 7 days
1Y Performance -22.79% Past 12 months
Model Rating
Historical model output for research review

Fundamental data date

Mar 31, 2026

103 days old

Market price date

Jul 10, 2026

2 days old

Coverage

16/16

No missing model inputs

Data quality

Excellent

Current stored snapshot

Transparent research score

Why the model scores this stock

MaveScore is a research prioritization score from 0 to 100. It is historical model output for watchlist review, not personalized financial advice.

MaveScore 46 Low confidence

Stored data quality

Freshness and coverage checks

16/16 Current stored snapshot

Quality

23/35 Mixed

Blends latest model rank with profitability and dilution ranks.

Financial Strength

14/25 Mixed

Rewards durable profitability, margins, and positive free cash flow.

Valuation Support

2/15 Weak

Favors positive earnings, positive cash flow, and lower multiples.

Momentum

1/15 Weak

Highlights research candidates with supportive 3-month and 6-month price regimes.

Shareholder Alignment

6/10 Mixed

Rewards less dilutive share behavior and enough size for liquid research coverage.

Positive model output

More live company inputs are needed before positive research signals can be surfaced.

Research risks to review

  • Favors positive earnings, positive cash flow, and lower multiples.
  • Highlights research candidates with supportive 3-month and 6-month price regimes.

MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting.

Dashboard Funda..tals Prediction Screener Map

Intuitive Surgical Inc Overview

Industry: Medical Instruments & Supplies

Sector: Healthcare

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California. Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery us Read More

Intuitive Surgical Inc is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.

Intuitive Surgical Inc

Score

Reported Results

What the company reported, with filing details kept small.

Filed Apr 21, 2026

Quarterly result summary

Revenue was $2.8B (+23% YoY); EPS was $ (reported).

Revenue $2.8B +23% YoY
EPS $ reported
Net income $826M +3% YoY
Cash $1.1B reported

What changed

  • Revenue +23% YoY to $2.8B; EPS reported to $.
  • Net income +3% YoY to $826M.

Guidance / outlook

The Company expects the following results for the full year of 2026: • Worldwide da Vinci procedure growth of approximately 13.5% to 15.5% in 2026. • Non-GAAP* gross profit margin to be within a range of 67.5% and 68.5% of revenue in 2026. This range includes an estimated impact from tariffs of 1.0% of revenue.

Earnings release Open filing

Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

Other recent earnings materials

Recent News



Earnings Per Share

Score 3.00/5
Intuitive Surgical Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
In Medical Instruments & Supplies industry , West Pharmaceutical Services Inc , Hologic Inc , Haemonetics are companies with high ratings.

Return on Equity

Score 4.45/5
Intuitive Surgical Inc stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
Intuitive Su... ISRG US$144.4b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Net Margin

Score 4.94/5
Intuitive Surgical Inc commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
Intuitive Su... ISRG US$144.4b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Share Buyback

In Medical Instruments & Supplies industry , West Pharmaceutical Services Inc , Hologic Inc , Haemonetics are companies with high ratings.

Leverage

Score 3.72/5
Intuitive Surgical Inc attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc , also exhibit high scores.
Intuitive Su... ISRG US$144.4b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Agilent Tech... A US$37.9b

Financial Statements

Company-reported SEC EDGAR facts organized into the three core statements.

SEC financial statements are temporarily unavailable.

Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

Financial Ratio

Yearly Quarterly

Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios

Intuitive Surgical Inc logo

Intuitive Surgical Inc

US$407.35

US$119.55

-71.0% vs price

US$144.4b

-4.64%

-22.79%